All supplements

Supplement evidence

093 / 575Cognition

Bacopa monnieri

View my plan

The short answer

Some 8–12 week trials report modest memory effects in healthy adults; acute effects are not expected.

Evidence and scope
Conditional or population-specific

This status does not grade the ingredient for every goal, outcome, or person.

Important limitation
Benefit depends on the population, formulation, baseline status, and objective; results should not be generalized.
Before deciding
Key concern: Thyroid, cholinergic, sedative, bradycardia, ulcer, pregnancy, and liver concerns require review.

01 / PRACTICAL GUIDE

Dose, absorption, and combinations

These are indication-specific reference or studied ranges—not a personalized prescription. Start with the objective, then check the form, label, medicines, and health conditions.

Reference range by objective
Cognitive-performance research300 mg/day extract standardized to bacosides in many trials

Reference or studied range—not a personalized prescription. The product label or a clinician may specify a different dose.

Dose source

More is not automatically better. A clinician or product label may specify a different amount.

Absorption / solubilityFat-soluble / lipid-based

Fat-soluble or lipid-based. Absorption generally improves with a meal containing fat.

How it is commonly taken

Take with food containing fat to reduce GI effects.

Do not combine casually

Thyroid, cholinergic, sedative, bradycardia, ulcer, pregnancy, and liver concerns require review.

Dose and use source

Dose and use links lead to primary or official source material. Search links are discovery tools, not proof that every returned paper applies.

02 / EVIDENCE

What the research says

We keep supportive, mixed, negative, safety, and contextual findings together. The headline never replaces the underlying papers.

2research papers in this ledger
7unique primary studies represented
101unique participants represented

These are audited counts for this JIVANA collection, not search-result totals. Participants are counted once when multiple papers use the same cohort; review papers are not added again to participant totals.

Open the research timelineResearch timeline

Entries are ordered by publication year. A study period appears only when the source reports it.

2025
Does not support the tested claimPMID 41091332 · ACTRN12623000475640

Bacumen Bacopa extract for cognition, stress, and fatigue

Bacopa did not improve any primary cognitive outcome. Selected secondary stress and fatigue measures improved, while digestive complaints and headaches were more frequent; those secondary findings need replication.

Study design and methods
Design
Randomized, double-blind, placebo-controlled parallel trial
Population
101 adults aged 40–70 with self-reported memory and attention problems; 87 completed
Intervention
Proprietary Bacumen Bacopa extract 300 mg/day versus placebo
Outcome
Primary verbal learning, attention, and working memory; secondary stress and fatigue; adverse events

Funding or conflict note: Both authors worked for Clinical Research Australia, which receives nutraceutical-company funding; one reported nutraceutical honoraria.

Open research record
2012
Mixed or qualifiedPMID 22747190

Cognitive-enhancing effects of Bacopa monnieri in adults without impairment

Bacopa improved 9 of 17 free-recall memory tests, but little evidence supported other cognitive domains. Few trials, varying extracts, inconsistent measures, and absent participant totals limit the claim to a possible memory-specific effect.

Study design and methods
Design
Systematic review of 6 randomized controlled trials
Population
Adults without dementia or significant cognitive impairment; total participant count was not reported in the abstract
Intervention
Three Bacopa extracts at 300–450 mg/day
Outcome
Validated memory and other cognitive tests
Open research record
Unscreened discovery appendix—not evidence16 candidate publicationsSearch run: Aug 21, 2026

Complete for the displayed PubMed query at the search timestamp—not for all databases or every possible synonym. Candidates can be irrelevant, duplicate the same study, or report negative findings. They are never summed as evidence or participants until screened.

03 / SOURCES

Start with the source material

The live search is for discovery only. Search-result counts change and are not included in the audited totals above.

Recent PubMed discovery recordsDirect links to the first 12 records returned by the reproducible search. These are discovery candidates—not reviewed summaries or a count of supportive findings.
  1. Neurometabolite changes in cingulate cortex regions in healthy Indian population and effect of Bacopa monnieri intervention: a H(1) MRS study.Singh AD, Kumar M, Bh S et al. · 2026 · Neurochemistry international · PMID 42102930Open on PubMed
  2. Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis.Tiemtad P, Ingkaninan K, Temkitthawon P et al. · 2026 · Phytomedicine : international journal of phytotherapy and phytopharmacology · PMID 41678913Open on PubMed
  3. The Effects of a Bacopa monnieri Extract (Bacumen(®)) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.Lopresti AL, Smith SJ · 2025 · Clinical drug investigation · PMID 41091332Open on PubMed
  4. Neurocognitive effects a combined polyphenolic-rich herbal extract in healthy middle-aged adults - a randomised, double-blind, placebo-controlled study.Best T, Miller J, Teo WP · 2024 · Nutritional neuroscience · PMID 38512715Open on PubMed
  5. Evaluating the effects of Bacopa monnieri on cognitive performance and sleep quality of patients with mild cognitive impairment: A triple-blinded, randomized, placebo-controlled trial.Delfan M, Kordestani-Moghaddam P, Gholami M et al. · 2024 · Explore (New York, N.Y.) · PMID 38538390Open on PubMed
  6. A systematic review of the safety and efficacy on cognitive function of herbal and nutritional medicines in older adults with and without subjective cognitive impairment.Cave AE, Chang DH, Münch GW et al. · 2023 · Systematic reviews · PMID 37592293Open on PubMed
  7. Effects of Bacopa monnieri (CDRI 08®) in a population of males exhibiting inattention and hyperactivity aged 6 to 14 years: A randomized, double-blind, placebo-controlled trial.Kean JD, Downey LA, Sarris J et al. · 2022 · Phytotherapy research : PTR · PMID 35041248Open on PubMed
  8. Short-Term Impact of a Combined Nutraceutical on Cognitive Function, Perceived Stress and Depression in Young Elderly with Cognitive Impairment: A Pilot, Double-Blind, Randomized Clinical Trial.Cicero AF, Bove M, Colletti A et al. · 2017 · The journal of prevention of Alzheimer's disease · PMID 29188854Open on PubMed
  9. A Randomized Controlled Trial Investigating the Effects of a Special Extract of Bacopa monnieri (CDRI 08) on Hyperactivity and Inattention in Male Children and Adolescents: BACHI Study Protocol (ANZCTRN12612000827831).Kean JD, Kaufman J, Lomas J et al. · 2015 · Nutrients · PMID 26633481Open on PubMed
  10. Management of cognitive determinants in senile dementia of Alzheimer's type: therapeutic potential of a novel polyherbal drug product.Sadhu A, Upadhyay P, Agrawal A et al. · 2014 · Clinical drug investigation · PMID 25316430Open on PubMed
  11. An acute, double-blind, placebo-controlled cross-over study of 320 mg and 640 mg doses of Bacopa monnieri (CDRI 08) on multitasking stress reactivity and mood.Benson S, Downey LA, Stough C et al. · 2014 · Phytotherapy research : PTR · PMID 23788517Open on PubMed
  12. Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract.Kongkeaw C, Dilokthornsakul P, Thanarangsarit P et al. · 2014 · Journal of ethnopharmacology · PMID 24252493Open on PubMed

04 / EXPERT CONTEXT

Expert context—not evidence

Expert positions are dated context—not scientific evidence. They never raise the evidence status or become consensus by repetition.

No direct, source-verified endorsement is currently recorded. Research authorship or discussion alone is not treated as endorsement.

Educational information only—not medical advice. Product quality, dose, medicines, pregnancy, and kidney or liver disease can materially change safety.